Assyro AI

FDA Orange Book · active-ingredient family

Cefuroxime sodium

Cefuroxime sodium is approved as 3 brand and 17 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

3

Brand (NDA)

17

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINERRLD×2B BRAUNNDA 050780Feb 21, 2001
ZINACEF IN PLASTIC CONTAINERRLD×2PAI HOLDINGS PHARMNDA 050643Apr 28, 1989
ZINACEFRLD×3PAI HOLDINGS PHARMNDA 050558Oct 19, 1983

Generic (ANDA) products (17)

ProductApplicantApplicationTEApproved
CEFUROXIME SODIUM IN PLASTIC CONTAINER×2SAMSON MEDCLANDA 065251Dec 30, 2009
CEFUROXIME SODIUM×2HOSPIRA INCANDA 065483Oct 15, 2008
CEFUROXIME SODIUMHOSPIRA INCANDA 065503Oct 15, 2008
CEFUROXIME SODIUMHOSPIRA INCANDA 065484Oct 15, 2008
CEFUROXIME SODIUM×2HIKMAANDA 065048APJan 09, 2004
CEFUROXIME SODIUMHIKMAANDA 065046Jan 09, 2004
CEFUROXIME SODIUM×2FRESENIUS KABI USAANDA 065001May 30, 2001
CEFUROXIME SODIUMFRESENIUS KABI USAANDA 065002Sep 28, 1998
CEFUROXIME SODIUMTEVA PHARMSANDA 064191Apr 16, 1998
CEFUROXIME SODIUM×2TEVA PHARMSANDA 064192Apr 16, 1998
CEFUROXIME SODIUM×2ACS DOBFAR SPAANDA 064125APMay 30, 1997
CEFUROXIME SODIUMACS DOBFAR SPAANDA 064124May 30, 1997
CEFUROXIME SODIUM×2WATSON LABS INCANDA 064035Feb 26, 1993
CEFUROXIME SODIUMWATSON LABS INCANDA 064036Feb 26, 1993
KEFUROX×3ACS DOBFARANDA 062591Jan 10, 1986
KEFUROX×2LILLYANDA 062592Jan 10, 1986
KEFUROX IN PLASTIC CONTAINER×2LILLYANDA 062590Jan 10, 1986

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Cefuroxime sodium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.